Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 25, 2025Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )Open Access

Impact of Clinical Pharmacist Intervention and Dapagliflozin Add-On Therapy on Glycemic Control in Type 2 Diabetes

View Full Paper
Ask AI
Bookmark
Share

Authors

MAMohammad Feroz AminRRRawa RathaTMTaha Mahwi

Discussion

Loading...

Member takes

Overview

Randomized controlled trial shows dapagliflozin and pharmacist intervention improve glycemic control in type 2 diabetes, suggesting benefits for medication adherence.

Key Points

  • Clinical pharmacist interventions improved medication adherence significantly, reaching 95%.
  • The average reduction in HbA1c was -0.7% for dapagliflozin and -0.665% for pharmacist interventions, indicating effective glycemic control.
  • Adverse events were low across all groups, with hypoglycemia rates ranging from 4.5% to 7.3%.
  • Type 2 diabetes patients receiving pharmacist-led care achieved better adherence rates compared to standard therapy, benefiting overall management.

Cite This Study

Amin et al. (2025) studied this question.

synapsesocial.com/papers/68af7b187567bf4f94ff271ahttps://doi.org/10.54133/ajms.v9i1.2339
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Improvement of Cardiometabolic Control with Dapagliflozin in Patients with Type 2 Diabetes in Primary Care: The AGORA-AP Study2025
  2. 2Effects of Dapagliflozin on Obese Patients With Type 2 Diabetes: A Prospective Observational Study From Bangladesh2025
  3. 3Effects of Dapagliflozin vs. Vildagliptin on the Lipid Profile of Patients With Uncontrolled Type 2 Diabetes2025 · 3 citations
  4. 4Study of the clinical effect of dapagliflozin on metabolic indices in type 2 diabetic patients with different obesity phenotypes2025
  5. 5Pioglitazone as Add-On to Metformin and Dapagliflozin Yields Significant Enhancements in Glycemic Control in Poorly Controlled Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials2025